[go: up one dir, main page]

ES2128629T3 - Derivados de bencilpiperidina con afinidad elevada a puntos de enlace de receptores de aminoacidos. - Google Patents

Derivados de bencilpiperidina con afinidad elevada a puntos de enlace de receptores de aminoacidos.

Info

Publication number
ES2128629T3
ES2128629T3 ES95116458T ES95116458T ES2128629T3 ES 2128629 T3 ES2128629 T3 ES 2128629T3 ES 95116458 T ES95116458 T ES 95116458T ES 95116458 T ES95116458 T ES 95116458T ES 2128629 T3 ES2128629 T3 ES 2128629T3
Authority
ES
Spain
Prior art keywords
sub
bencilpiperidine
derivatives
amino acid
sup
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95116458T
Other languages
English (en)
Inventor
Helmut Pruecher
Joachim Leibrock
Rudolf Gottschlich
Harry Schwartz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4438810A external-priority patent/DE4438810A1/de
Priority claimed from DE1995126269 external-priority patent/DE19526269A1/de
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2128629T3 publication Critical patent/ES2128629T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

DERIVADOS BENCILPIPERIDINA DE LA FORMULA I DONDE R 1 ES H, HAL O NITRO, R{SUP, 2} ES UN GRUPO BENCILO INSUSTITUIDO O SUSTITUIDO POR HAL EN AROMATICOS EN LA POSICION 2,3 O 4 DEL ANILLO PIPERIDINA, CON LA CONDICION DE QUE R{SUP, 2} NO ES IGUAL A 4 - BENCILO, CUANDO X SIGNIFICA - CO -, Y Y Z SIGNIFICA CH{SUB, 2} - Y R{SUP, 1} SIGNIFICA H, R{SUP, 3} ES H O A, X ES - CO - O - SO{SUB, 2} -, Y ES - CH{SUB, 2} -, - NH -, - O -, S -, O TAMBIEN - CO -, CUANDO X ES - CO - Y Z ES - NH -, - NA -, Z ES - CH{SUB, 2} -, - C(A){SUB, 2} -, - CH{SUB, 2}CH{SUB, 2} -, - CH = CH{SUB, 2} -, - CO -, - NH -, - NA -, - O -, O UN ENLACE, DONDE UNO DE LOS RESTOS X, Y Y Z PUEDEN SER - O -, - S -, O - NH -, SIN EMBARGO X - Y O Y - Z NO SON - O - O -, - S S -, - NH O -, - O - NH -, - NH - NH -, - O -, - S -, - SO -, A ES ALQUILO CON 1 - 6 ATOMOS DE C Y B ES O, H + OH, HAL ES F, CL, BR O I N ES 0,1,2 ASI COMO SUS SALES QUE MUESTRAN UNA ALTA AFINIDAD A LUGARES DE ENLACE DE RECEPTORES DE AMINOACIDOS Y SON APROPIADOS PARA TRATAMIENTO DE ENFERMEDADES NEURODEGENERATIVAS.
ES95116458T 1994-10-31 1995-10-19 Derivados de bencilpiperidina con afinidad elevada a puntos de enlace de receptores de aminoacidos. Expired - Lifetime ES2128629T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4438810A DE4438810A1 (de) 1994-10-31 1994-10-31 Benzylpiperidinderivate
DE1995126269 DE19526269A1 (de) 1995-07-19 1995-07-19 Benzylpiperidinderivate

Publications (1)

Publication Number Publication Date
ES2128629T3 true ES2128629T3 (es) 1999-05-16

Family

ID=25941544

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95116458T Expired - Lifetime ES2128629T3 (es) 1994-10-31 1995-10-19 Derivados de bencilpiperidina con afinidad elevada a puntos de enlace de receptores de aminoacidos.

Country Status (23)

Country Link
US (1) US5698553A (es)
EP (1) EP0709384B1 (es)
JP (1) JPH08225569A (es)
KR (1) KR100388593B1 (es)
CN (1) CN1064358C (es)
AT (1) ATE174915T1 (es)
AU (1) AU703487B2 (es)
BR (1) BR9505008A (es)
CA (1) CA2161618A1 (es)
CZ (1) CZ288039B6 (es)
DE (1) DE59504622D1 (es)
DK (1) DK0709384T3 (es)
ES (1) ES2128629T3 (es)
FI (1) FI955184L (es)
GR (1) GR3029771T3 (es)
HU (1) HUT76068A (es)
NO (1) NO310023B1 (es)
PL (1) PL182210B1 (es)
RU (1) RU2160259C2 (es)
SK (1) SK282476B6 (es)
TR (1) TR199501331A2 (es)
TW (1) TW394770B (es)
UA (1) UA41927C2 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0709384B1 (de) * 1994-10-31 1998-12-23 MERCK PATENT GmbH Benzylpiperidinderivate mit hoher Affinität zu Bindungsstellen von Aminosäure-Rezeptoren
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
DE19643790A1 (de) * 1996-10-30 1998-05-07 Merck Patent Gmbh Benzoxazol-Derivat
US6110935A (en) * 1997-02-13 2000-08-29 The Regents Of The University Of California Benzofurazan compounds for enhancing glutamatergic synaptic responses
AU6852898A (en) * 1997-04-17 1998-11-11 Takeda Chemical Industries Ltd. Thermogenic composition and benzazepine thermogenics
GB9725541D0 (en) * 1997-12-02 1998-02-04 Pharmacia & Upjohn Spa Amino-benzothiazole derivatives
DE19812331A1 (de) 1998-03-20 1999-09-23 Merck Patent Gmbh Piperidinderivate
US6340685B1 (en) 1998-05-22 2002-01-22 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
US6130235A (en) * 1998-05-22 2000-10-10 Scios Inc. Compounds and methods to treat cardiac failure and other disorders
US6867209B1 (en) 1998-05-22 2005-03-15 Scios, Inc. Indole-type derivatives as inhibitors of p38 kinase
US6448257B1 (en) 1998-05-22 2002-09-10 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
US6589954B1 (en) 1998-05-22 2003-07-08 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
NZ508790A (en) * 1998-05-22 2003-10-31 Scios Inc Heterocyclic compounds and methods to treat cardiac failure and other disorders
PE20000728A1 (es) 1998-06-26 2000-08-21 Cocensys Inc Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda
IL146309A (en) 1999-05-21 2008-03-20 Scios Inc Derivatives of the indole type and pharmaceutical preparations containing them as inhibitors of kinase p38
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
DE10120159A1 (de) * 2001-04-25 2002-10-31 Merck Patent Gmbh NMDA-Antagonisten und NMDA-Agonisten zur Behandlung von Suchterkrankungen
WO2003035641A1 (en) * 2001-10-22 2003-05-01 Shionogi & Co., Ltd. Novel carbamoylpyrrolidone derivative
DE10210779A1 (de) * 2002-03-12 2003-10-09 Merck Patent Gmbh Cyclische Amide
DE10217006A1 (de) 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
JP4459048B2 (ja) * 2002-06-11 2010-04-28 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア 垂直電界測定を使用する海底地質調査の方法およびシステム
ITTO20040124A1 (it) * 2004-03-01 2004-06-01 Medestea Internaz Srl Nuovi impieghi in terapia di derivati di n-piperidina particolarmente per il trattamento di patologie neurodegenerative
JPWO2005097782A1 (ja) * 2004-04-07 2007-08-16 協和醗酵工業株式会社 ピペリジン誘導体
PT2144506E (pt) * 2007-01-03 2011-12-21 Servier Lab Composto de [1,2,3]-benzotriazinona substituída em posição 3 para aumentar as respostas glutamatérgicas nas sinapses
DE102007047737A1 (de) * 2007-10-05 2009-04-30 Merck Patent Gmbh Piperidin- und Piperazinderivate
TWI410420B (zh) * 2008-02-05 2013-10-01 Dainippon Sumitomo Pharma Co 苄基哌啶化合物
EP2463286A4 (en) 2009-08-04 2013-01-23 Dainippon Sumitomo Pharma Co BENZYLPIPERIDINVERBINDUNG
DE102009049211A1 (de) 2009-10-13 2011-04-28 Merck Patent Gmbh Sulfoxide
JP5829510B2 (ja) * 2010-12-21 2015-12-09 住友化学株式会社 高分子化合物及びそれを用いた発光素子
US20130270486A1 (en) * 2010-12-21 2013-10-17 Sumitomo Chemical Company, Limited Polymer compound and light-emitting device using same
KR102277538B1 (ko) * 2015-06-08 2021-07-14 주식회사 대웅제약 신규한 헤테로 고리 화합물, 이의 제조 방법 및 이를 포함하는 약학적 조성물
AR110963A1 (es) * 2017-02-07 2019-05-22 Dae Woong Pharma Compuestos heterocíclicos, su método de preparación y composición farmacéutica que los comprende

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FI77852C (fi) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat.
JPS57142972A (en) * 1981-02-27 1982-09-03 Otsuka Pharmaceut Co Ltd Carbostyril derivative
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
JPH0753913B2 (ja) * 1990-11-14 1995-06-07 新日本製鐵株式会社 有機複合めっき鋼板の製造方法
US5338361A (en) * 1991-11-04 1994-08-16 Measurex Corporation Multiple coat measurement and control apparatus and method
FR2688504B1 (fr) * 1992-03-13 1995-05-05 Synthelabo Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
EP0709384B1 (de) * 1994-10-31 1998-12-23 MERCK PATENT GmbH Benzylpiperidinderivate mit hoher Affinität zu Bindungsstellen von Aminosäure-Rezeptoren

Also Published As

Publication number Publication date
UA41927C2 (uk) 2001-10-15
CZ288039B6 (cs) 2001-04-11
SK282476B6 (sk) 2002-02-05
SK135595A3 (en) 1996-06-05
DE59504622D1 (de) 1999-02-04
TW394770B (en) 2000-06-21
FI955184A0 (fi) 1995-10-30
KR100388593B1 (ko) 2003-09-19
CN1128762A (zh) 1996-08-14
CN1064358C (zh) 2001-04-11
EP0709384A1 (de) 1996-05-01
RU2160259C2 (ru) 2000-12-10
KR960014119A (ko) 1996-05-22
DK0709384T3 (da) 1999-08-23
FI955184A7 (fi) 1996-05-01
HUT76068A (en) 1997-06-30
GR3029771T3 (en) 1999-06-30
BR9505008A (pt) 1997-10-14
PL311185A1 (en) 1996-05-13
CA2161618A1 (en) 1996-05-01
NO310023B1 (no) 2001-05-07
PL182210B1 (pl) 2001-11-30
EP0709384B1 (de) 1998-12-23
CZ281695A3 (en) 1996-05-15
NO954349L (no) 1996-05-02
US5698553A (en) 1997-12-16
NO954349D0 (no) 1995-10-30
HU9503101D0 (en) 1995-12-28
AU3443595A (en) 1996-05-09
TR199501331A2 (tr) 1996-06-21
FI955184L (fi) 1996-05-01
AU703487B2 (en) 1999-03-25
JPH08225569A (ja) 1996-09-03
ATE174915T1 (de) 1999-01-15

Similar Documents

Publication Publication Date Title
ES2128629T3 (es) Derivados de bencilpiperidina con afinidad elevada a puntos de enlace de receptores de aminoacidos.
PT641328E (pt) Derivados aza-biciclicos em ponte como antagonistas da substancia p
ES2059327T3 (es) Derivados de tetrahidronaftaleno y de indano, obtencion de los mismos y utilizacion en preparados farmaceuticos.
ES2173172T3 (es) Derivados de 1,3-dihidroindol-2-ona sustituidos en 3 por un grupo nitrogenado como agonistas y/o antagonistas de la vasopresina y/o de la octocina.
ES2113368T3 (es) Antagonistas de serotonina.
MX9304996A (es) Heterociclos no-aromaticos que contienen bencilamino nitrogeno substituido.
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
ES2031513T3 (es) Quinazolindionas y piridopirimidinadionas.
ES2138977T3 (es) Agonistas muscarinicos.
MX168017B (es) Composiciones dielectricos adecuadas para formar un patron con luz, metodo para su formacion y uso
ES2056928T3 (es) Compuestos heterociclicos.
DK0607164T3 (da) Kondenserede tricykliske nitrogenholdige heterocykliske forbindelser som substans P-receptorantagonister
AR001413A1 (es) Compuestos triciclicos de carbamato, utiles para la inhibición de la función de la proteina g y paratratamiento de enfermedades proliferativas.
CY1106224T1 (el) Νεα παραγωγα 4-αποδιμεθυλαμινο τετρακυκλινης
AR002690A1 (es) Derivado de bencimidazol o sales del mismo, composicion farmaceutica, agente inmunosupresor y agente antiinflamatorio que lo contienen yprocedimientos para preparar dicho derivado.
CO4650117A1 (es) Derivados de bencilsulfuro y proceso para su produccion .
ES2055035T3 (es) Un proceso para la preparacion de un glicosido de antraciclina.
ES2093099T3 (es) Preparacion de piperidinas sustituidas.
ES2132882T3 (es) Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina 1.
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
ES2196069T3 (es) Derivados morfinoides condensados con heterociclos.
ES2058849T3 (es) Benzanilidas.
AR021094A1 (es) Compuestos heterociclicos inhibidores de la fosfodiesterasa iv y su uso para el tratamiento de enfermedades inflamatorias
MX9403011A (es) Nuevos compuestos derivados de la1,2-etanodiamina-n,n,n',n'-tetrasustituida.
ES2145480T3 (es) Amidas de acido carbamoilcarboxilico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 709384

Country of ref document: ES